The DOI matches its Crossref record; 204 of the 204 references it cites were found in a registry or an index.
Emerging concepts in dendrimer‐based nanomedicine: from design principles to clinical applications
Abstract
Dendrimers are discrete nanostructures/nanoparticles with ‘onion skin‐like’ branched layers. Beginning with a core, these nanostructures grow in concentric layers to produce stepwise increases in size that are similar to the dimensions of many in vivo globular proteins. These branched tree‐like concentric layers are referred to as ‘generations’. The outer generation of each dendrimer presents a precise number of functional groups that may act as a monodispersed platform for engineering favourable nanoparticle–drug and nanoparticle–tissue interactions. These features have attracted significant attention in medicine as nanocarriers for traditional small drugs, proteins, DNA/RNA and in some instances as intrinsically active nanoscale drugs. Dendrimer‐based drugs, as well as diagnostic and imaging agents, are emerging as promising candidates for many nanomedicine applications. First, we will provide a brief survey of recent nanomedicines that are either approved or in the clinical approval process. This will be followed by an introduction to a new ‘nanoperiodic’ concept which proposes nanoparticle structure control and the engineering of ‘critical nanoscale design parameters’ (CNDP s) as a strategy for optimizing pharmocokinetics, pharmocodynamics and site‐specific targeting of disease. This paradigm has led to the emergence of CNDP‐directed nanoperiodic property patterns relating nanoparticle behaviour to critical in vivo clinical translation issues such as cellular uptake, transport, elimination, biodistribution, accumulation and nanotoxicology. With a focus on dendrimers, these CNDP‐directed nanoperiodic patterns are used as a strategy for designing and optimizing nanoparticles for a variety of drug delivery and imaging applications, including a recent dendrimer‐based theranostic nanodevice for imaging and treating cancer. Several emerging preclinical dendrimer‐based nanotherapy concepts related to inflammation, neuro‐inflammatory disorders, oncology and infectious and ocular diseases are reviewed. Finally we will consider challenges and opportunities anticipated for future clinical translation, nanotoxicology and the commercialization of nanomedicine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toxic potential of materials at the nanolevel
Nel, A., Xia, T., Mädler, L., & Li, N. (2006) · Science · doi:10.1126/science.1114397 · Cited by 9,324
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
Maeda, H., Wu, J., Sawa, T., Matsumura, Y., & Hori, K. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00248-5 · Cited by 6,565
Renal clearance of quantum dots
Soo Choi, H., Liu, W., Misra, P., Tanaka, E., Zimmer, J. P., Itty Ipe, B., Bawendi, M. G., & Frangioni, J. V. (2007) · Nature Biotechnology · doi:10.1038/nbt1340 · Cited by 4,476
More Is Different: Broken symmetry and the nature of the hierarchical structure of science.
Anderson, P. W. (1972) · Science · doi:10.1126/science.177.4047.393 · Cited by 4,018
A New Class of Polymers: Starburst-Dendritic Macromolecules
Tomalia, D. A., Baker, H., Dewald, J., Hall, M., Kallos, G., Martin, S., Roeck, J., Ryder, J., & Smith, P. (1985) · Polymer Journal · doi:10.1295/polymj.17.117 · Cited by 3,904
Self-citationBlock copolymer micelles for drug delivery: design, characterization and biological significance
Kataoka, K., Harada, A., & Nagasaki, Y. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00124-1 · Cited by 3,506
The dawning era of polymer therapeutics
Duncan, R. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1088 · Cited by 3,269
Tomalia, D. A., Naylor, A. M., & Goddard, W. A. (1990) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199001381 · Cited by 3,211
Self-citationShape effects of filaments versus spherical particles in flow and drug delivery
Geng, Y., Dalhaimer, P., Cai, S., Tsai, R., Tewari, M., Minko, T., & Discher, D. E. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.70 · Cited by 2,565
Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size
Cabral, H., Matsumoto, Y., Mizuno, K., Chen, Q., Murakami, M., Kimura, M., Terada, Y., Kano, M. R., Miyazono, K., Uesaka, M., et al. (2011) · Nature Nanotechnology · doi:10.1038/nnano.2011.166 · Cited by 2,429
Longmire, M., Choyke, P. L., & Kobayashi, H. (2008) · Nanomedicine · doi:10.2217/17435889.3.5.703 · Cited by 2,149
Designing dendrimers for biological applications
Lee, C. C., MacKay, J. A., Fréchet, J. M. J., & Szoka, F. C. (2005) · Nature Biotechnology · doi:10.1038/nbt1171 · Cited by 2,043
Size‐Dependent Cytotoxicity of Gold Nanoparticles
Pan, Y., Neuss, S., Leifert, A., Fischler, M., Wen, F., Simon, U., Schmid, G., Brandau, W., & Jahnen‐Dechent, W. (2007) · Small · doi:10.1002/smll.200700378 · Cited by 1,878
More Is Different: Broken symmetry and the nature of the hierarchical structure of science.
Anderson, P. W. (1972) · Science · Cited by 1,734
The emerging nanomedicine landscape
Wagner, V., Dullaart, A., Bock, A.-K., & Zweck, A. (2006) · Nature Biotechnology · doi:10.1038/nbt1006-1211 · Cited by 1,630
Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications
Esfand, R., & Tomalia, D. A. (2001) · Drug Discovery Today · doi:10.1016/s1359-6446(01)01757-3 · Cited by 1,562
Self-citationApplications of Orthogonal “Click” Chemistries in the Synthesis of Functional Soft Materials
Iha, R. K., Wooley, K. L., Nyström, A. M., Burke, D. J., Kade, M. J., & Hawker, C. J. (2009) · Chemical Reviews · doi:10.1021/cr900138t · Cited by 1,468
Theranostics: Combining Imaging and Therapy
Kelkar, S. S., & Reineke, T. M. (2011) · Bioconjugate Chemistry · doi:10.1021/bc200151q · Cited by 1,385
Malik, N., Wiwattanapatapee, R., Klopsch, R., Lorenz, K., Frey, H., Weener, J. W., Meijer, E. W., Paulus, W., & Duncan, R. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00246-1 · Cited by 1,227
Dendron-Mediated Self-Assembly, Disassembly, and Self-Organization of Complex Systems
Rosen, B. M., Wilson, C. J., Wilson, D. A., Peterca, M., Imam, M. R., & Percec, V. (2009) · Chemical Reviews · doi:10.1021/cr900157q · Cited by 1,204
What the Cell “Sees” in Bionanoscience
Walczyk, D., Bombelli, F. B., Monopoli, M. P., Lynch, I., & Dawson, K. A. (2010) · Journal of the American Chemical Society · doi:10.1021/ja910675v · Cited by 1,184
Dendrimer biocompatibility and toxicity
DUNCAN, R., & IZZO, L. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.09.019 · Cited by 1,158
Kim, B. Y. S., Rutka, J. T., & Chan, W. C. W. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0912273 · Cited by 1,147
Tomalia, D. A. (2005) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2005.01.007 · Cited by 1,115
Self-citationStructure and properties of pharmacologically active polymers
Ringsdorf, H. (1975) · Journal of Polymer Science: Polymer Symposia · doi:10.1002/polc.5070510111 · Cited by 1,094
The antiquity of RNA-based evolution.
Joyce, G. F. (2002) · Nature · doi:10.1038/418214a · Cited by 1,070
The molecular architecture of the nuclear pore complex
Alber, F., Dokudovskaya, S., Veenhoff, L. M., Zhang, W., Kipper, J., Devos, D., Suprapto, A., Karni-Schmidt, O., Williams, R., Chait, B. T., et al. (2007) · Nature · doi:10.1038/nature06405 · Cited by 1,057
Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology
Oberdörster, G. (2010) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2009.02187.x · Cited by 943
Discovery of dendrimers and dendritic polymers: A brief historical perspective*
Tomalia, D. A., & Fréchet, J. M. J. (2002) · Journal of Polymer Science Part A: Polymer Chemistry · doi:10.1002/pola.10301 · Cited by 908
Self-citationTumor imaging by means of proteolytic activation of cell-penetrating peptides
Jiang, T., Olson, E. S., Nguyen, Q. T., Roy, M., Jennings, P. A., & Tsien, R. Y. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408191101 · Cited by 822
Strategies for advancing cancer nanomedicine
Chauhan, V. P., & Jain, R. K. (2013) · Nature Materials · doi:10.1038/nmat3792 · Cited by 812
In Vitro Gene Delivery by Degraded Polyamidoamine Dendrimers
Tang, M. X., Redemann, C. T., & Szoka, F. C. (1996) · Bioconjugate Chemistry · doi:10.1021/bc9600630 · Cited by 808
Physicochemical Properties Determine Nanomaterial Cellular Uptake, Transport, and Fate
Zhu, M., Nie, G., Meng, H., Xia, T., Nel, A., & Zhao, Y. (2013) · Accounts of Chemical Research · doi:10.1021/ar300031y · Cited by 803
Dendrimer toxicity: Let's meet the challenge
Jain, K., Kesharwani, P., Gupta, U., & Jain, N. K. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.04.027 · Cited by 710
Biomedical applications of dendrimers: a tutorial
Mintzer, M. A., & Grinstaff, M. W. (2011) · Chem. Soc. Rev. · doi:10.1039/b901839p · Cited by 671
Interactions between dendrimer biocides and bacterial membranes
Chen, C. Z., & Cooper, S. L. (2002) · Biomaterials · doi:10.1016/s0142-9612(02)00036-4 · Cited by 663
Toxicology for the twenty-first century
Hartung, T. (2009) · Nature · doi:10.1038/460208a · Cited by 661
Transforming Environmental Health Protection
Collins, F. S., Gray, G. M., & Bucher, J. R. (2008) · Science · doi:10.1126/science.1154619 · Cited by 630
Nanotechnology in Therapeutics: A Focus on Nanoparticles as A Drug Delivery System
Bamrungsap, S., Zhao, Z., Chen, T., Wang, L., Li, C., Fu, T., & Tan, W. (2012) · Nanomedicine · doi:10.2217/nnm.12.87 · Cited by 606
Nel, A., Xia, T., Meng, H., Wang, X., Lin, S., Ji, Z., & Zhang, H. (2013) · Accounts of Chemical Research · doi:10.1021/ar300022h · Cited by 579
Olson, E. S., Jiang, T., Aguilera, T. A., Nguyen, Q. T., Ellies, L. G., Scadeng, M., & Tsien, R. Y. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910283107 · Cited by 567
Factors Controlling Nanoparticle Pharmacokinetics: An Integrated Analysis and Perspective
Moghimi, S. M., Hunter, A. C., & Andresen, T. L. (2012) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010611-134623 · Cited by 545
Dendrimers as multi-purpose nanodevices for oncology drug delivery and diagnostic imaging
Tomalia, D. A., Reyna, L. A., & Svenson, S. (2007) · Biochemical Society Transactions · doi:10.1042/bst0350061 · Cited by 496
Self-citationNguyen, Q. T., Olson, E. S., Aguilera, T. A., Jiang, T., Scadeng, M., Ellies, L. G., & Tsien, R. Y. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910261107 · Cited by 474
Fluorescent Silica Nanoparticles with Efficient Urinary Excretion for Nanomedicine
Burns, A. A., Vider, J., Ow, H., Herz, E., Penate-Medina, O., Baumgart, M., Larson, S. M., Wiesner, U., & Bradbury, M. (2009) · Nano Letters · doi:10.1021/nl803405h · Cited by 474
Chauhan, V. P., Popović, Z., Chen, O., Cui, J., Fukumura, D., Bawendi, M. G., & Jain, R. K. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201104449 · Cited by 473
Gold Nanoparticles: A Revival in Precious Metal Administration to Patients
Thakor, A. S., Jokerst, J., Zavaleta, C., Massoud, T. F., & Gambhir, S. S. (2011) · Nano Letters · doi:10.1021/nl202559p · Cited by 468
Dendrimers in Oncology: An Expanding Horizon
Tekade, R. K., Kumar, P. V., & Jain, N. K. (2009) · Chemical Reviews · doi:10.1021/cr068212n · Cited by 466
The long and short of carbon nanotube toxicity
Kostarelos, K. (2008) · Nature Biotechnology · doi:10.1038/nbt0708-774 · Cited by 436
Multifunctional dendritic polymers in nanomedicine: opportunities and challenges
Khandare, J., Calderón, M., Dagia, N. M., & Haag, R. (2012) · Chem. Soc. Rev. · doi:10.1039/c1cs15242d · Cited by 418
Dendrimer-platinate: a novel approach to cancer chemotherapy.
Malik, N., Evagorou, E. G., & Duncan, R. (1999) · PubMed · Cited by 417
Dendrimer−Silver Complexes and Nanocomposites as Antimicrobial Agents
Balogh, L., Swanson, D. R., Tomalia, D. A., Hagnauer, G. L., & McManus, A. T. (2001) · Nano Letters · doi:10.1021/nl005502p · Cited by 412
Self-citationCharacterization of Nanoparticles for Therapeutics
Hall, J. B., Dobrovolskaia, M. A., Patri, A. K., & McNeil, S. E. (2007) · Nanomedicine · doi:10.2217/17435889.2.6.789 · Cited by 409
Dendrimer-platinate: a novel approach to cancer chemotherapy
Malik, N., Evagorou, E. G., & Duncan, R. (1999) · Anti-Cancer Drugs · doi:10.1097/00001813-199909000-00010 · Cited by 402
Dendrimer-Based Postnatal Therapy for Neuroinflammation and Cerebral Palsy in a Rabbit Model
Kannan, S., Dai, H., Navath, R. S., Balakrishnan, B., Jyoti, A., Janisse, J., Romero, R., & Kannan, R. M. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003162 · Cited by 399
Self-citationNanodrugs: pharmacokinetics and safety
Onoue, S., Yamada, S., & Chan, K. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s38378 · Cited by 382
The effect of surface functionality on cellular trafficking of dendrimers
Perumal, O. P., Inapagolla, R., Kannan, S., & Kannan, R. M. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.04.038 · Cited by 379
Self-citationFrom Macromolecules to Biological Assemblies (Nobel Lecture)
Klug, A. (1983) · Angewandte Chemie International Edition in English · doi:10.1002/anie.198305653 · Cited by 378
Meng, H., Yang, S., Li, Z., Xia, T., Chen, J., Ji, Z., Zhang, H., Wang, X., Lin, S., Huang, C., et al. (2011) · ACS Nano · doi:10.1021/nn103344k · Cited by 362
Mayer, L. D., Tai, L. C. L., Ko, D. S. C., Masin, D., Ginsberg, R. S., Cullis, P. R., & Bally, M. B. (1989) · PubMed · Cited by 353
Lee, H., Fonge, H., Hoang, B., Reilly, R. M., & Allen, C. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100038h · Cited by 349
Mignani, S., El Kazzouli, S., Bousmina, M., & Majoral, J.-P. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.01.001 · Cited by 335
Polyvalent dendrimer glucosamine conjugates prevent scar tissue formation
Shaunak, S., Thomas, S., Gianasi, E., Godwin, A., Jones, E., Teo, I., Mireskandari, K., Luthert, P., Duncan, R., Patterson, S., et al. (2004) · Nature Biotechnology · doi:10.1038/nbt995 · Cited by 331
Singh, P., Gupta, U., Asthana, A., & Jain, N. K. (2008) · Bioconjugate Chemistry · doi:10.1021/bc800125u · Cited by 329
Rivera Gil, P., Oberdörster, G., Elder, A., Puntes, V., & Parak, W. J. (2010) · ACS Nano · doi:10.1021/nn1025687 · Cited by 314
Natural Products: Bioactivity, Biochemistry, and Biological Effects in Cancer and Disease Therapy
Chang, H.-W., Chuang, L.-Y., Guleria, S., & Yasmin, S. (2013) · The Scientific World Journal · doi:10.1155/2013/713480 · Cited by 313
Transepithelial transport and toxicity of PAMAM dendrimers: Implications for oral drug delivery
Sadekar, S., & Ghandehari, H. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.09.010 · Cited by 311
Simplifying the synthesis of dendrimers: accelerated approaches
Walter, M. V., & Malkoch, M. (2012) · Chemical Society Reviews · doi:10.1039/c2cs35062a · Cited by 301
Nanoparticles for multimodal in vivo imaging in nanomedicine
Leary, J., & Key, J. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s53717 · Cited by 300
Theranostic Nanoparticles Engineered for Clinic and Pharmaceutics
Ma, X., Zhao, Y., & Liang, X.-J. (2011) · Accounts of Chemical Research · doi:10.1021/ar2000056 · Cited by 297
Cell-Specific, Activatable, and Theranostic Prodrug for Dual-Targeted Cancer Imaging and Therapy
Santra, S., Kaittanis, C., Santiesteban, O. J., & Perez, J. M. (2011) · Journal of the American Chemical Society · doi:10.1021/ja207463b · Cited by 295
Orthogonality in organic, polymer, and supramolecular chemistry: from Merrifield to click chemistry
Wong, C.-H., & Zimmerman, S. C. (2013) · Chemical Communications · doi:10.1039/c2cc37316e · Cited by 292
Hamad, I., Al-Hanbali, O., Hunter, A. C., Rutt, K. J., Andresen, T. L., & Moghimi, S. M. (2010) · ACS Nano · doi:10.1021/nn101990a · Cited by 276
Dendrimers, Dendrons, and Dendritic Polymers: Discovery, Applications, and the Future
Tomalia, D. A., Christensen, J. B., & Boas, U. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9781139048859 · Cited by 257
Self-citationIn quest of a systematic framework for unifying and defining nanoscience
Tomalia, D. A. (2009) · Journal of Nanoparticle Research · doi:10.1007/s11051-009-9632-z · Cited by 255
Self-citationA Phosphorus-Based Dendrimer Targets Inflammation and Osteoclastogenesis in Experimental Arthritis
Hayder, M., Poupot, M., Baron, M., Nigon, D., Turrin, C.-O., Caminade, A.-M., Majoral, J.-P., Eisenberg, R. A., Fournié, J.-J., Cantagrel, A., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002212 · Cited by 241
Dobrovolskaia, M. A., Patri, A. K., Simak, J., Hall, J. B., Semberova, J., De Paoli Lacerda, S. H., & McNeil, S. E. (2012) · Molecular Pharmaceutics · doi:10.1021/mp200463e · Cited by 223
Lacerda, L., Soundararajan, A., Singh, R., Pastorin, G., Al‐Jamal, K. T., Turton, J., Frederik, P., Herrero, M. A., Li, S., Bao, A., et al. (2008) · Advanced Materials · doi:10.1002/adma.200702334 · Cited by 211
Folate‐targeted nanoparticles show efficacy in the treatment of inflammatory arthritis
Thomas, T. P., Goonewardena, S. N., Majoros, I. J., Kotlyar, A., Cao, Z., Leroueil, P. R., & Baker, J. R. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30459 · Cited by 208
Cationic PAMAM Dendrimers Aggressively Initiate Blood Clot Formation
Jones, C. F., Campbell, R. A., Brooks, A. E., Assemi, S., Tadjiki, S., Thiagarajan, G., Mulcock, C., Weyrich, A. S., Brooks, B. D., Ghandehari, H., et al. (2012) · ACS Nano · doi:10.1021/nn303472r · Cited by 207
Yang, H., Tyagi, P., Kadam, R. S., Holden, C. A., & Kompella, U. B. (2012) · ACS Nano · doi:10.1021/nn301873v · Cited by 207
Theoretical and computational studies of dendrimers as delivery vectors
Tian, W.-D., & Ma, Y.-Q. (2013) · Chem. Soc. Rev. · doi:10.1039/c2cs35306g · Cited by 205
Tomalia, D. A. (2010) · Soft Matter · doi:10.1039/b917370f · Cited by 204
Self-citationKaminskas, L. M., Boyd, B. J., & Porter, C. J. (2011) · Nanomedicine · doi:10.2217/nnm.11.67 · Cited by 204
Synthesis and Biological Response of Size-Specific, Monodisperse Drug–Silica Nanoconjugates
Tang, L., Fan, T. M., Borst, L. B., & Cheng, J. (2012) · ACS Nano · doi:10.1021/nn300149c · Cited by 203
Iezzi, R., Guru, B. R., Glybina, I. V., Mishra, M. K., Kennedy, A., & Kannan, R. M. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2011.10.010 · Cited by 192
Self-citationKaminskas, L. M., McLeod, V. M., Ryan, G. M., Kelly, B. D., Haynes, J. M., Williamson, M., Thienthong, N., Owen, D. J., & Porter, C. J. H. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.03.012 · Cited by 190
Valencia, P. M., Hanewich-Hollatz, M. H., Gao, W., Karim, F., Langer, R., Karnik, R., & Farokhzad, O. C. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.04.078 · Cited by 184
Oliveira, J. M., Salgado, A. J., Sousa, N., Mano, J. F., & Reis, R. L. (2010) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2010.04.006 · Cited by 182
Chauhan, A. S., Diwan, P. V., Jain, N. K., & Tomalia, D. A. (2009) · Biomacromolecules · doi:10.1021/bm9000298 · Cited by 182
Self-citationDesigning hydrogel adhesives for corneal wound repair
Grinstaff, M. W. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.08.041 · Cited by 182
Albertazzi, L., Gherardini, L., Brondi, M., Sulis Sato, S., Bifone, A., Pizzorusso, T., Ratto, G. M., & Bardi, G. (2013) · Molecular Pharmaceutics · doi:10.1021/mp300391v · Cited by 181
Conscripts of the infinite armada: systemic cancer therapy using nanomaterials
Scheinberg, D. A., Villa, C. H., Escorcia, F. E., & McDevitt, M. R. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.38 · Cited by 180
Linear-dendritic drug conjugates forming long-circulating nanorods for cancer-drug delivery
Zhou, Z., Ma, X., Jin, E., Tang, J., Sui, M., Shen, Y., Van Kirk, E. A., Murdoch, W. J., & Radosz, M. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.04.012 · Cited by 178
Size-Dependent Tumor Penetration and in Vivo Efficacy of Monodisperse Drug–Silica Nanoconjugates
Tang, L., Gabrielson, N. P., Uckun, F. M., Fan, T. M., & Cheng, J. (2013) · Molecular Pharmaceutics · doi:10.1021/mp300684a · Cited by 174
Price, C. F., Tyssen, D., Sonza, S., Davie, A., Evans, S., Lewis, G. R., Xia, S., Spelman, T., Hodsman, P., Moench, T. R., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024095 · Cited by 173
Tomalia, D. A., Huang, B., SWANSON, D. R., Brothers, H. M., & Klimash, J. W. (2003) · Tetrahedron · doi:10.1016/s0040-4020(03)00430-7 · Cited by 171
Self-citationBoyd, B. J., Kaminskas, L. M., Karellas, P., Krippner, G., Lessene, R., & Porter, C. J. H. (2006) · Molecular Pharmaceutics · doi:10.1021/mp060032e · Cited by 167
Size and surface charge significantly influence the toxicity of silica and dendritic nanoparticles
Greish, K., Thiagarajan, G., Herd, H., Price, R., Bauer, H., Hubbard, D., Burckle, A., Sadekar, S., Yu, T., Anwar, A., et al. (2012) · Nanotoxicology · doi:10.3109/17435390.2011.604442 · Cited by 166
Activity of Dendrimer−Methotrexate Conjugates on Methotrexate-Sensitive and -Resistant Cell Lines
Gurdag, S., Khandare, J., Stapels, S., Matherly, L. H., & Kannan, R. M. (2006) · Bioconjugate Chemistry · doi:10.1021/bc0501855 · Cited by 165
Self-citationTaratula, O., Schumann, C., Naleway, M. A., Pang, A. J., Chon, K. J., & Taratula, O. (2013) · Molecular Pharmaceutics · doi:10.1021/mp400397t · Cited by 165
Triazine dendrimers as drug delivery systems: From synthesis to therapy
Lim, J., & Simanek, E. E. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.03.008 · Cited by 164
Chu, K. S., Hasan, W., Rawal, S., Walsh, M. D., Enlow, E. M., Luft, J. C., Bridges, A. S., Kuijer, J. L., Napier, M. E., Zamboni, W. C., et al. (2012) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2012.11.008 · Cited by 162
Zhou, J., Neff, C. P., Liu, X., Zhang, J., Li, H., Smith, D. D., Swiderski, P., Aboellail, T., Huang, Y., Du, Q., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2011.207 · Cited by 161
Jiang, Y.-H., Emau, P., Cairns, J. S., Flanary, L., Morton, W. R., McCarthy, T. D., & Tsai, C.-C. (2005) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2005.21.207 · Cited by 160
Regulating Nanomedicine – Can the FDA Handle It?
Bawa, R. (2011) · Current Drug Delivery · doi:10.2174/156720111795256156 · Cited by 160
Exploiting Dendrimer Multivalency To Combat Emerging and Re-Emerging Infectious Diseases
Mintzer, M. A., Dane, E. L., O’Toole, G. A., & Grinstaff, M. W. (2012) · Molecular Pharmaceutics · doi:10.1021/mp2005033 · Cited by 159
Yang, Y., Sunoqrot, S., Stowell, C., Ji, J., Lee, C.-W., Kim, J. W., Khan, S. A., & Hong, S. (2012) · Biomacromolecules · doi:10.1021/bm300545b · Cited by 158
Chauhan, A. S., Jain, N. K., Diwan, P. V., & Khopade, A. J. (2004) · Journal of Drug Targeting · doi:10.1080/10611860400010655 · Cited by 158
Theranostics: Are We There Yet?
Svenson, S. (2013) · Molecular Pharmaceutics · doi:10.1021/mp300644n · Cited by 156
Mishra, M. K., Beaty, C. A., Lesniak, W. G., Kambhampati, S. P., Zhang, F., Wilson, M. A., Blue, M. E., Troncoso, J. C., Kannan, S., Johnston, M. V., et al. (2014) · ACS Nano · doi:10.1021/nn404872e · Cited by 155
Self-citationWang, B., Navath, R. S., Menjoge, A. R., Balakrishnan, B., Bellair, R. J., Dai, H., Romero, R. J., Kannan, S., & Kannan, R. M. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.05.030 · Cited by 154
Self-citationTomalia, D. A. (2011) · New Journal of Chemistry · doi:10.1039/c1nj20501c · Cited by 154
Self-citationFox, M. E., Guillaudeu, S. J., Fréchet, J. M. J., Jerger, K., Macaraeg, N., & Szoka, F. C. (2009) · Molecular Pharmaceutics · doi:10.1021/mp9001206 · Cited by 150
Joyce, G. F. (1992) · Scientific American · doi:10.1038/scientificamerican1292-90 · Cited by 148
Choi, S. K., Myc, A., Silpe, J. E., Sumit, M., Wong, P. T., McCarthy, K. A., Desai, A. M., Thomas, T. P., Kotlyar, A., Holl, M. M. B., et al. (2012) · ACS Nano · doi:10.1021/nn3038995 · Cited by 148
Prevention of Influenza Pneumonitis by Sialic Acid–Conjugated Dendritic Polymers
Landers, J. J., Cao, Z., Lee, I., Piehler, L. T., Myc, P. P., Myc, A., Hamouda, T., Gałecki, A. T., & Baker, J. R. (2002) · The Journal of Infectious Diseases · doi:10.1086/344316 · Cited by 143
Iyer, M., Mishra, R. K., Han, Y., & Hopfinger, A. J. (2002) · Pharmaceutical Research · doi:10.1023/a:1020792909928 · Cited by 142
Kobayashi, H., Sato, N., Hiraga, A., Saga, T., Nakamoto, Y., Ueda, H., Konishi, J., Togashi, K., & Brechbiel, M. W. (2001) · Magnetic Resonance in Medicine · Cited by 141
Designing Dendrimers for Drug Delivery and Imaging: Pharmacokinetic Considerations
Wijagkanalan, W., Kawakami, S., & Hashida, M. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0339-8 · Cited by 139
Cationic PAMAM Dendrimers Disrupt Key Platelet Functions
Jones, C. F., Campbell, R. A., Franks, Z. G., Gibson, C. C., Thiagarajan, G., Vieira‐de‐Abreu, A., Sukavaneshvar, S., Mohammad, S., Li, D. Y., Ghandehari, H., et al. (2012) · Molecular Pharmaceutics · doi:10.1021/mp2006054 · Cited by 138
RGD-modified PEG–PAMAM–DOX conjugates: In vitro and in vivo studies for glioma
Zhang, L., Zhu, S., Qian, L., Pei, Y., Qiu, Y., & Jiang, Y. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2011.03.025 · Cited by 137
Dendrimer-based MRI contrast agents: the effects of PEGylation on relaxivity and pharmacokinetics
Kojima, C., Türkbey, B., Ogawa, M., Bernardo, M., Regino, C. A. S., Bryant, L. H., Choyke, P. L., Kono, K., & Kobayashi, H. (2011) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2011.03.007 · Cited by 134
Duncan, R., Ringsdorf, H., & Satchi‐Fainaro, R. (2006) · Journal of drug targeting · doi:10.1080/10611860600833856 · Cited by 132
Dendrimer Nanoscaffolds for Potential Theranostics of Prostate Cancer with a Focus on Radiochemistry
Lo, S., Kumar, A., Hsieh, J., & Sun, X. (2013) · Molecular Pharmaceutics · doi:10.1021/mp3005325 · Cited by 131
Sato, N., Kobayashi, H., Hiraga, A., Saga, T., Togashi, K., Konishi, J., & Brechbiel, M. W. (2001) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1314 · Cited by 130
Novel RNA oligonucleotide improves liver function and inhibits liver carcinogenesis in vivo
Reebye, V., Sætrom, P., Mintz, P. J., Huang, K., Swiderski, P. M., Peng, L., Liu, C., Liu, X., Lindkær-Jensen, S., Zacharoulis, D., et al. (2013) · Hepatology · doi:10.1002/hep.26669 · Cited by 126
Self-citationDendrimer Nanoparticles for Ocular Drug Delivery
Kambhampati, S. P., & Kannan, R. M. (2013) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2012.0232 · Cited by 124
Self-citationDai, H., Navath, R. S., Balakrishnan, B., Guru, B. R., Mishra, M. K., Romero, R. J., Kannan, R. M., & Kannan, S. (2010) · Nanomedicine · doi:10.2217/nnm.10.89 · Cited by 123
Self-citationDendrimeric Systems and Their Applications in Ocular Drug Delivery
Yavuz, B., Pehlivan, S. B., & Ünlü, N. (2013) · The Scientific World JOURNAL · doi:10.1155/2013/732340 · Cited by 120
Single-Walled Carbon Nanotube Surface Control of Complement Recognition and Activation
Andersen, A. J., Robinson, J. T., Dai, H., Hunter, A. C., Andresen, T. L., & Moghimi, S. M. (2013) · ACS Nano · doi:10.1021/nn3055175 · Cited by 118
Bernstein, D. I., Stanberry, L. R., Sacks, S. H., Ayisi, N. K., Gong, Y., Ireland, J., Mumper, R. J., Holan, G., Matthews, B. R., McCarthy, T. D., et al. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.12.3784-3788.2003 · Cited by 116
Precision Synthesis of Subnanoparticles Using Dendrimers as a Superatom Synthesizer
Yamamoto, K., & Imaoka, T. (2014) · Accounts of Chemical Research · doi:10.1021/ar400257s · Cited by 116
Ali, M., Liu, G., Shah, T. V., Flask, C. A., & Pagel, M. D. (2009) · Accounts of Chemical Research · doi:10.1021/ar8002738 · Cited by 115
The treatment of Glioblastoma Xenografts by surfactant conjugated dendritic nanoconjugates
Gajbhiye, V., & Jain, N. K. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.04.057 · Cited by 115
Subconjunctival Nanoparticle Carboplatin in the Treatment of Murine Retinoblastoma
Kang, S. J. (2009) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2009.185 · Cited by 113
Sato, N., Kobayashi, H., Saga, T., Nakamoto, Y., Ishimori, T., Togashi, K., Fujibayashi, Y., Konishi, J., & Brechbiel, M. W. (2001) · PubMed · Cited by 109
Kojima, C., Regino, C. A. S., Umeda, Y., Kobayashi, H., & Kono, K. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.09.015 · Cited by 108
(2007) · CRC Press eBooks · doi:10.3109/9781420045154 · Cited by 107
Giri, J., Diallo, M. S., Simpson, A. J., Liu, Y., Goddard, W. A., Kumar, R., & Woods, G. C. (2011) · ACS Nano · doi:10.1021/nn1021007 · Cited by 107
Synthesis, Radiolabeling, and Bio-imaging of High-Generation Polyester Dendrimers
Parrott, M. C., Benhabbour, S. R., Saab, C., Lemon, J. A., Parker, S., Valliant, J. F., & Adronov, A. (2009) · Journal of the American Chemical Society · doi:10.1021/ja8078175 · Cited by 107
Reshaping the Future of Nanopharmaceuticals: Ad Iudicium
Moghimi, S. M., Peer, D., & Langer, R. (2011) · ACS Nano · doi:10.1021/nn2038252 · Cited by 105
Dendritic PARACEST contrast agents for magnetic resonance imaging
Pikkemaat, J. A., Wegh, R. T., Lamerichs, R. M. J. N., van de Molengraaf, R. A., Langereis, S., Burdinski, D., Raymond, A. Y. F., Janssen, H. M., de Waal, B. F. M., Willard, N. P., et al. (2007) · Contrast Media & Molecular Imaging · doi:10.1002/cmmi.149 · Cited by 103
PEGylated Peptide Dendrimeric Carriers for the Delivery of Antimalarial Drug Chloroquine Phosphate
Bhadra, D., Bhadra, S., & Jain, N. K. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-9396-9 · Cited by 102
Bringing nanomedicines to market: regulatory challenges, opportunities, and uncertainties
Nijhara, R., & Balakrishnan, K. (2006) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2006.04.005 · Cited by 100
Dendrimers for gene delivery – a potential approach for ocular therapy?
Chaplot, S. P., & Rupenthal, I. D. (2013) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12104 · Cited by 98
Stoichiometry and Structure of Poly(amidoamine) Dendrimer−Lipid Complexes
Kelly, C. V., Liroff, M. G., Triplett, L. D., et al. (2009) · ACS Nano · doi:10.1021/nn900173e · Cited by 97
Glycodendrimers as functional antigens and antitumor vaccines
Shiao, T. C., & Roy, R. (2011) · New Journal of Chemistry · doi:10.1039/c2nj20873c · Cited by 93
Koppu, S., Oh, Y. J., Edrada‐Ebel, R., Blatchford, D. R., Tetley, L., Tate, R. J., & Dufès, C. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.11.015 · Cited by 92
Oligo(ethylene glycol)-Based Thermosensitive Dendrimers and Their Tumor Accumulation and Penetration
Wu, W., Driessen, W. H. P., & Jiang, X. (2014) · Journal of the American Chemical Society · doi:10.1021/ja411457r · Cited by 91
Kobayashi, H., Kawamoto, S., Saga, T., Sato, N., Hiraga, A., Konishi, J., Togashi, K., & Brechbiel, M. W. (2001) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.10025 · Cited by 88
Vincent, L., Varet, J., Pille, J., Bompais, H., Opolon, P., Maksimenko, A., Malvy, C., Mirshahi, M., Lu, H., Vannier, J., et al. (2003) · International Journal of Cancer · doi:10.1002/ijc.11105 · Cited by 88
64 Cu-Labeled LyP-1-Dendrimer for PET-CT Imaging of Atherosclerotic Plaque
Seo, J. W., Baek, H., Mahakian, L. M., Kusunose, J., Hamzah, J., Ruoslahti, E. I., & Ferrara, K. W. (2014) · Bioconjugate Chemistry · doi:10.1021/bc400347s · Cited by 87
Inapagolla, R., Guru, B. R., Kurtoglu, Y. E., Gao, X., Lieh-Lai, M. W., Bassett, D. J. P., & Kannan, R. M. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.07.030 · Cited by 85
Self-citationStimuli sensitive amphiphilic dendrimers
Ramireddy, R. R., Raghupathi, K. R., Torres, D. A., & Thayumanavan, S. (2012) · New Journal of Chemistry · doi:10.1039/c2nj20879b · Cited by 82
Navarro, G., Maiwald, G., Haase, R., Rogach, A. L., Wagner, E., de Ilarduya, C. T., & Ogris, M. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.04.030 · Cited by 79
Dendrimer‐Based Drug Delivery Systems
Najlah, M., Zhou, Z., & DEmanuele, A. (2012) · Wiley eBooks · doi:10.1002/9781118275238 · Cited by 77
Jiao, A. L., & Slack, F. J. (2013) · Epigenetics · doi:10.4161/epi.26942 · Cited by 77
Kumar, P. V., Agashe, H. B., Dutta, T., & Jain, N. K. (2006) · Current Drug Delivery · doi:10.2174/156720107779314794 · Cited by 77
Olson, E. S., Whitney, M. A., Friedman, B., Aguilera, T. A., Crisp, J. L., Baik, F. M., Jiang, T., Baird, S. M., Tsimikas, S., Tsien, R. Y., et al. (2012) · Integrative Biology · doi:10.1039/c2ib00161f · Cited by 76
Liu, X., Wu, J., Yammine, M., Zhou, J., Posocco, P., Viel, S., Liu, C., Ziarelli, F., Fermeglia, M., Pricl, S., et al. (2011) · Bioconjugate Chemistry · doi:10.1021/bc200275g · Cited by 76
Kaminskas, L. M., McLeod, V. M., Kelly, B. D., Cullinane, C. M., Sberna, G., Williamson, M., Boyd, B. J., Owen, D. J., & Porter, C. J. H. (2012) · Molecular Pharmaceutics · doi:10.1021/mp200522d · Cited by 73
Implementation of alternative test strategies for the safety assessment of engineered nanomaterials
Nel, A. E. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12109 · Cited by 72
Jiang, Y., Tang, G., Zhang, L.-H., Kong, S.-Y., Zhu, S., & Pei, Y. (2010) · Journal of drug targeting · doi:10.3109/10611860903494203 · Cited by 72
Lothian-Tomalia, M. K., Hedstrand, D. M., Tomalia, D. A., et al. (1997) · Tetrahedron · doi:10.1016/s0040-4020(97)00976-9 · Cited by 68
Self-citationDendrimer therapeutics: covalent and ionic attachments
Kazzouli, S. E., Mignani, S. M., Bousmina, M., & Majoral, J. (2011) · New Journal of Chemistry · doi:10.1039/c1nj20459a · Cited by 61
Dendrimer-enabled DNA delivery and transformation of Chlamydia pneumoniae
Gérard, H. C., Mishra, M. K., Mao, G., Wang, S., Hali, M., Whittum‐Hudson, J. A., Kannan, R. M., & Hudson, A. P. (2013) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2013.04.004 · Cited by 59
Self-citationLy, T. U., Trân, N. Q., Hoang, T. K. D., Phan, K. N., Truong, H. N., & Nguyen, C. K. (2013) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2013.1479 · Cited by 59
Dendrimers in Biomedical Applications
(2013) · Royal Society of Chemistry eBooks · doi:10.1039/9781849737296 · Cited by 59
Considerations When Submitting Nanotherapeutics to FDA/CDER for Regulatory Review
Tyner, K. M., & Sadrieh, N. K. (2010) · Methods in molecular biology · doi:10.1007/978-1-60327-198-1_3 · Cited by 57
Dendritic Nanoparticles: the Next Generation of nanocarriers?
Pearson, R. M., Sunoqrot, S., Hsu, H.-J., Bae, J. W., & Hong, S. (2012) · Therapeutic Delivery · doi:10.4155/tde.12.76 · Cited by 57
Castonguay, A., Ladd, E., van de Ven, T. G. M., & Kakkar, A. K. (2011) · New Journal of Chemistry · doi:10.1039/c1nj20481e · Cited by 57
Development and Application of a Multimodal Contrast Agent for SPECT/CT Hybrid Imaging
Criscione, J. M., Dobrucki, L. W., Zhuang, Z. W., Papademetris, X., Simons, M., Sinusas, A. J., & Fahmy, T. M. (2011) · Bioconjugate Chemistry · doi:10.1021/bc200162r · Cited by 55
Rios‐Doria, J., Carie, A., Costich, T. L., Burke, B., Skaff, H., Panicucci, R., & Sill, K. (2012) · Journal of Drug Delivery · doi:10.1155/2012/951741 · Cited by 53
Size-dependent biodistribution and antitumor efficacy of polymer micelle drug delivery systems
Yue, J., Liu, S., Xie, Z., Xing, Y., & Jing, X. (2013) · Journal of Materials Chemistry B · doi:10.1039/c3tb20296h · Cited by 51
Dendrimers—revolutionary drugs for infectious diseases
Łaźniewska, J., Miłowska, K., & Gabryelak, T. (2012) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1181 · Cited by 51
Klajnert‐Maculewicz, B., Cangiotti, M., Calici, S., Йонов, М., Majoral, J., Caminade, A., Cladera, J., Bryszewska, M. J., & Ottaviani, M. F. (2009) · New Journal of Chemistry · doi:10.1039/b820632p · Cited by 51
Berdahl, J. P. (2009) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2008.582 · Cited by 51
Koç, F. E., & Şenel, M. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.04.062 · Cited by 50
Functionalized Congener Approach to the Design of Ligands for G Protein-Coupled Receptors (GPCRs)
Jacobson, K. A. (2009) · Bioconjugate Chemistry · doi:10.1021/bc9000596 · Cited by 49
Theranostic Nanomedicine with Functional Nanoarchitecture
Pan, D. (2013) · Molecular Pharmaceutics · doi:10.1021/mp400044j · Cited by 49
Influence of Surface Groups on Poly(propylene imine) Dendrimers Antiprion Activity
McCarthy, J. M., Rasines, B., Filippini, D., Komber, H., Maly, M., Cernescu, M., Brutschy, B., Appelhans, D., & Rogers, M. S. (2012) · Biomacromolecules · doi:10.1021/bm301165u · Cited by 47
Heterogeneity in Nanoparticles Influences Biodistribution and Targeting
Adjei, I. M., Peetla, C., & Labhasetwar, V. D. (2013) · Nanomedicine · doi:10.2217/nnm.13.70 · Cited by 47
Clinically Relevant Anticancer Polymer Paclitaxel Therapeutics
Yang, D., Yu, L., & Van, S. (2010) · Cancers · doi:10.3390/cancers3010017 · Cited by 45
Handbook of Immunological Properties of Engineered Nanomaterials
Dobrovolskaia, M. A., & McNeil, S. E. (2012) · Frontiers in nanobiomedical research · doi:10.1142/8390 · Cited by 45
Karton-Lifshin, N., & Shabat, D. (2011) · New Journal of Chemistry · doi:10.1039/c1nj20486f · Cited by 44
Zou, Y., Ling, Y., Reddy, S., Priebe, W., & Perez-Soler, R. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910610513 · Cited by 40
Nanosafety: towards safer design of nanomedicines
Fadeel, B. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12137 · Cited by 40
Neibert, K. D., Gosein, V., Sharma, A., Khan, M., Whitehead, M. A., Maysinger, D., & Kakkar, A. K. (2013) · Molecular Pharmaceutics · doi:10.1021/mp4000508 · Cited by 40
Nanomedicine: reshaping clinical practice
Fadeel, B., Kasemo, B., Malmsten, M., & Strømme, M. (2009) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2009.02186.x · Cited by 39
Nanodynamics of Dendritic Core–Multishell Nanocarriers
Boreham, A., Pfaff, M., Fleige, E., Haag, R., & Alexiev, U. (2014) · Langmuir · doi:10.1021/la4043155 · Cited by 34
Whither antibacterial drug discovery?
Projan, S. J. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2008.03.010 · Cited by 32
Nanomedicine for prion disease treatment
McCarthy, J. M., Appelhans, D., Tatzelt, J., et al. (2013) · Prion · doi:10.4161/pri.24431 · Cited by 26
Slack, F. J. (2014) · Epigenetics · doi:10.4161/epi.27579 · Cited by 26
Dendrimer-enabled transformation of Chlamydia trachomatis
Kannan, R. M., Gérard, H. C., Mishra, M. K., Mao, G., Wang, S., Hali, M., Whittum‐Hudson, J. A., & Hudson, A. P. (2013) · Microbial Pathogenesis · doi:10.1016/j.micpath.2013.08.003 · Cited by 23
Self-citationDendrimers and the Development of New Complex Nanomaterials for Biomedical Applications
Gardikis, Κ., Micha‐Screttas, M., Demetzos, C., & Steele, B. R. (2012) · Current Medicinal Chemistry · doi:10.2174/0929867311209024913 · Cited by 23
Pavan, G. M., & Danani, A. (2010) · Physical Chemistry Chemical Physics · doi:10.1039/c0cp01124j · Cited by 21
IN QUEST OF A SYSTEMATIC FRAMEWORK FOR UNIFYING AND DEFINING NANOSCIENCE
Tomalia, D. A., & Khanna, S. N. (2014) · Modern Physics Letters B · doi:10.1142/s0217984914300026 · Cited by 19
Self-citationDifferentiating Prion Strains Using Dendrimers
McCarthy, J. M., Rasines, B., Appelhans, D., & Rogers, M. S. (2012) · Advanced Healthcare Materials · doi:10.1002/adhm.201200151 · Cited by 19
Bellare, J. R. (2011) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2011.1189 · Cited by 15
Cited by
Engineering precision nanoparticles for drug delivery
Mitchell, M. J., Billingsley, M. M., Haley, R. M., Wechsler, M. E., Peppas, N. A., & Langer, R. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0090-8 · Cited by 7,933
Nanomaterials for In Vivo Imaging
Smith, B. R., & Gambhir, S. S. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00073 · Cited by 1,075
Lombardo, D., Kiselev, M. A., & Caccamo, M. T. (2019) · Journal of Nanomaterials · doi:10.1155/2019/3702518 · Cited by 864
Clinical Translation of Nanomedicine
Min, Y., Caster, J. M., Eblan, M. J., & Wang, A. Z. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00116 · Cited by 772
Endocytosis: The Nanoparticle and Submicron Nanocompounds Gateway into the Cell
Manzanares, D., & Ceña, V. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12040371 · Cited by 488
Metadata
- Authors
- Kannan, R. M., Nance, E., Kannan, S., & Tomalia, D. A.
- Venue
- Journal of Internal Medicine
- Publisher
- Wiley
- Published
- 2014-07-31
- Volume
- 276
- Issue
- 6
- Pages
- 579-617
- ISSN
- 0954-6820 (ISSN-L)
- 1365-2796
- OpenAlex
- W2073439757
- Cited by
- 542
- References
- 204
- FWCI
- 37.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.